These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30413641)
1. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study. Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis. Peyro Saint Paul L; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Parienti JJ; Verdon R; Fournel F; Cattoir V; Lobbedez T Perit Dial Int; 2017 Jan; 37(1):44-50. PubMed ID: 27680760 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis. Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study. Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828 [TBL] [Abstract][Full Text] [Related]
6. Treatment of enterococcal peritonitis with intraperitoneal daptomycin in a vancomycin-allergic patient and a review of the literature. Gilmore JF; Kim M; LaSalvia MT; Mahoney MV Perit Dial Int; 2013; 33(4):353-7. PubMed ID: 23843587 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients. Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intraperitoneal epoetin alfa in patients on peritoneal dialysis using an 8-hour "dry dwell" dosing technique. Taylor CA; Kosorok MR; Zimmerman SW; Johnson CA Am J Kidney Dis; 1999 Oct; 34(4):657-62. PubMed ID: 10516346 [TBL] [Abstract][Full Text] [Related]
10. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis. Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis. Elwell RJ; Frye RF; Bailie GR Perit Dial Int; 2005; 25(4):380-6. PubMed ID: 16022096 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W Nephron; 1986; 43(3):217-22. PubMed ID: 3724930 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis. Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852 [TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal Meropenem for Polymicrobial Peritoneal Dialysis-Related Peritonitis. de Fijter CW; Jakulj L; Amiri F; Zandvliet A; Franssen E Perit Dial Int; 2016 9-10; 36(5):572-3. PubMed ID: 27659932 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807 [TBL] [Abstract][Full Text] [Related]
18. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD). Passlick J; Wonner R; Keller E; Essers L; Grabensee B Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379 [TBL] [Abstract][Full Text] [Related]
19. Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. Kampf D; Borner K; Hain H; Conrad W Perit Dial Int; 1991; 11(4):317-21. PubMed ID: 1751596 [TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal erythropoietin in children on peritoneal dialysis: A study of pharmacokinetics and efficacy. Kausz AT; Watkins SL; Hansen C; Godwin DA; Palmer RB; Brandt JR Am J Kidney Dis; 1999 Oct; 34(4):651-6. PubMed ID: 10516345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]